China Continues to Consult NCCN for Guidance on Cancer Treatment
The international presence of the National Comprehensive Cancer Network® (NCCN®) continues to flourish with a busy spring schedule of programs in China designed to allow Chinese and other Asian experts ample opportunity to share and exchange experiences with their counterparts in the United States.
March 24, 2010
FORT WASHINGTON, PA — Among recent reports that cancer diagnoses and deaths continue to decline in the United States, the same cannot be said about developing countries such as China where smoking, poor diet, water pollution, and environmental problems have caused the nation’s cancer death rate to rise 80 percent over the past 30 years. In an effort to curb the cancer rates, the country has adopted evidence-based treatment guidelines and continues to strengthen a number of strategic collaborations with the National Comprehensive Cancer Network® (NCCN®) as demonstrated by several NCCN programs scheduled throughout China this spring.
The 3rd Annual Asia Scientific Congress is scheduled for March 24 – 31, 2010 in Beijing, Shanghai, and Guangzhou and includes presentations discussing recent updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Breast, Colon, Gastric, Kidney, Non-Small Cell Lung, and Rectal Cancers. Last year, the 2nd Annual Congress attracted more than 3,000 physicians from across China and Asia.
In addition, a Breast Cancer Forum is scheduled for March 27 in Beijing. This forum will provide a platform for physicians from multiple Asian countries to present and share with their colleague Hope S. Rugo, MD of UCSF Medical Center and a member of several NCCN Guidelines Panels, the current perspective of breast cancer treatment in Asia.
Programs continue into the month of April; NCCN Guidelines Symposia on Ovarian Cancer, Cervical Cancer, and Head & Neck Cancers will be held on April 17 in Beijing.
In an effort to expand access to these programs to a larger audience throughout China, a webcast hosted by Andrew D. Zelenetz, MD, PhD, of Memorial Sloan-Kettering Cancer Center and Chair of the NCCN Guidelines for Non-Hodgkin’s Lymphomas (NHL) was held on March 23 and covered the NCCN Guidelines for NHL.
China has had a long-standing collaboration with NCCN in the development of the Chinese Editions of the NCCN Guidelines - the most authoritative reference for oncology practice in China.
NCCN regularly collaborates with international organizations to create and distribute translations of the NCCN Guidelines, which may include modifications representative of metabolic differences in populations, technological considerations, and regulatory status of agents used in cancer management, such as availabilities of drugs, biologics, devices, and procedures.
In 2009, NCCN approved Chinese Editions of the NCCN Guidelines for Breast, Cervical, Colon, Gastric, Head & Neck, Kidney, Non-Small Cell Lung, Ovarian, and Rectal Cancers, as well as Non-Hodgkin’s Lymphomas, which can be accessed at www.nccn.org/international.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- University of Wisconsin Carbone Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital